2012-09-19 13:35:11 - SADIF-Investment Analytics has applied its StockMarks™ stock-rating system to Beihai Gofar Marine Biological Industry and produced a Rating Update Report, rating the company's attractiveness to long-term investors.
Ilhavo, Portugal – SADIF Investment Analytics, announces a new Rating Update Report covering Beihai Gofar Marine Biological Industry (600538). The report uses SADIF's powerful StockMarks™ stock rating system and contains important analysis for any current or potential Beihai Gofar Marine Biological Industry investor.
Report Summary: Beihai Gofar Marine Biological Industry is an average quality company with a neutral outlook. Beihai Gofar Marine Biological Industry has weak business growth and is run by inefficient management. The trend in Beihai Gofar Marine Biological Industry fair value exchange rate against its closest rated-competitor, Anhui Huaxing Chemical Industry Co., Ltd, has been stable over the past 2 weeks. When compared to its closest competitor, Beihai Gofar Marine Biological Industry shows similar undervaluation and is equally
likely to outperform the market.
The 3-page report breaks down the Total StockMark into its three components – business, management and price, performing an in-depth analysis of Beihai Gofar Marine Biological Industry for long-term investors.
The report has been distributed to Thomson Reuters. It is available in Investext from multiple professional platforms including Thomson Research, Thomson ONE Banker, DIALOG/INTELLISCOPE, Thomson Gale, West Services, Advisen, Alacra-Datadownlink, Factiva, INTERNET SECURITIES and LEXIS/NEXIS or directly from SADIF-Investment Analytics at:
About SADIF-Investment Analytics:
SADIF-Investment Analytics is an independent investment research company covering sixteen different markets and over 12,000 companies. The StockMarks™ system is based on proven investment principles and is designed to drive long-term shareholder returns.